Explore the details of the Pfizer Inc. V. Orient Pharma Co., Ltd. case under case number 1:25cv00743 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25cv00743
Filing Date
Jun 16, 2025
Cause of Action
Patent Infringement
Status
-
Case Link
View Case
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
C.P. Pharmaceuticals International C.V. -
PF PRISM C.V. -
PBG Puerto Rico LLC -
Pfizer Inc. -
Orient Pharma Co., Ltd. -

Patents Involved in the Case

This case involves 3 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US9937181B2
-US11253523B2
-US10639309B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 16, 2025Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate C.P. Pharmaceuticals International C.V., Other Affiliate PF PRISM C.V., Other Affiliate PF PRISM IMB B.V., Other Affiliate PBG Puerto Rico LLC for Pfizer Inc. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (slk) (Entered: 06/17/2025)PACER Document
Jun 16, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,181 B2; 10,639,309 B2; 11,253,523 B2. (slk) (Entered: 06/17/2025)PACER Document
Jun 16, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On/Around May 1, 2025. Date of Expiration of Patent: All asserted patents expire March 14, 2034, Pursuant to 21 U.S.C. § 355a, pediatric exclusivity extends through September 14, 2034.Thirty Month Stay Deadline: 11/1/2027. (slk) (Entered: 06/17/2025)PACER Document
Jun 16, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) (Entered: 06/17/2025)PACER Document
Jun 16, 2025COMPLAINT filed against Orient Pharma Co., Ltd. (Filing fee $ 405, receipt number ADEDC-4712357.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(slk) (Entered: 06/17/2025)PACER Document
Jun 16, 2025No Summons Issued. (slk)PACER Document